Document Detail


Hemoperfusion and immunocorrection in acute stage of severely burned patients.
MedLine Citation:
PMID:  3501966     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The goal of this study was to explore the therapeutic effect of hemoperfusion and immunocorrection therapy in acute period of burn disease in severely injured patients. Hemoperfusion was performed in severely burned patients 1-3 times in the period from the 2nd to 10th day. The hemoperfusion procedures in severely burned patients were combined with immunocorrecting therapy. To prevent the development of septic complications in the early periods after the injury the patients were treated with passive immunotherapy supplemented with immunocorrecting substances. The patients were divided into two groups. The first group (26 persons) included patients treated with hemoperfusion followed by immunocorrection. The second group (11 persons) consisted of patients treated according to routine schemes. The studies carried out show that hemoperfusion with subsequent immunocorrection produced normalizing effect on indices of cellular and humoral immunity in severely burned patients. The efficacy of detoxication is attained both owing to blood depuration and due to detoxifying influence of directional effect immunoglobulins.
Authors:
T Sosyura; G Rozinets; N Povstyanoy
Related Documents :
7473946 - Increased levels of circulating interleukin-8 in patients with large burns: relation to...
8634136 - Predictors of post-traumatic stress disorder following burns injury.
9756366 - Assessment criteria in identifying the sick sepsis patient.
20061836 - Colloid administration normalizes resuscitation ratio and ameliorates "fluid creep".
3096806 - Development of hepatic cholestasis and fibrosis in patients with massive loss of intest...
21971486 - Shoulder pain in cases of spinal injury: influence of the position of the wheelchair s...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Biomaterials, artificial cells, and artificial organs     Volume:  15     ISSN:  0890-5533     ISO Abbreviation:  Biomater Artif Cells Artif Organs     Publication Date:  1987  
Date Detail:
Created Date:  1988-04-18     Completed Date:  1988-04-18     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8802605     Medline TA:  Biomater Artif Cells Artif Organs     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  611-6     Citation Subset:  IM    
Affiliation:
Kiev Research Institute of Hematology and Blood Transfusion, MH, Ukr.SSR.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
B-Lymphocytes / immunology
Burns / therapy*
Hemoperfusion*
Humans
Immunization, Passive*
T-Lymphocytes / immunology

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Relative binding affinity at metribolone androgenic binding sites of various antiandrogenic agents.
Next Document:  Lymphoma with clonal T-cell receptor gene rearrangement in a 25-year survivor of Hodgkin's disease.